A co-culture system of human intestinal Caco-2 cells and lymphoblastoid TK6 cells for investigating the genotoxicity of oral compounds

Mutagenesis

Volumn 27, Issue 6, 2012, Pages 631-636

  Le Hégarat, Ludovic ^a   Huet, Sylvie ^a   Fessard, Valérie ^a  

^a FRENCH AGENCY FOR FOOD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AFLATOXIN B1; BENZO[A]PYRENE; KETOCONAZOLE; MESYLIC ACID METHYL ESTER;

ARTICLE; CELL STRAIN CACO 2; COCULTURE; COMET ASSAY; CONTAMINATION; CYTOTOXICITY; DNA DAMAGE; FOOD CONTAMINATION; GENOTOXICITY; HUMAN; HUMAN CELL; INTESTINE CELL; LYMPHOBLASTOID CELL; MICRONUCLEUS; MICRONUCLEUS TEST; PRIORITY JOURNAL;

AFLATOXIN B1; BENZO(A)PYRENE; BIOTRANSFORMATION; CACO-2 CELLS; CELL LINE; COCULTURE TECHNIQUES; COMET ASSAY; DNA DAMAGE; HUMANS; METHYL METHANESULFONATE; MICRONUCLEUS TESTS; MUTAGENS;

EID: 84868549150     PISSN: 02678357     EISSN: 14643804     Source Type: Journal    
DOI: 10.1093/mutage/ges028     Document Type: Article

References (41)

1. Pfuhler, S., Fellows, M., van Benthem, J. et al. (2011) In vitro genotoxicity test approaches with better predictivity: summary of an IWGT Workshop. Mutat. Res., 723, 101-107.
2. Kirkland, D., Pfuhler, S., Tweats, D. et al. (2007) How to reduce false positive results when undertaking in vitro genotoxicity testing and thus avoid unnecessary follow-up animal tests: report of an ECVAM workshop. Mutat. Res., 628, 31-55.
3. Kirkland, D., Hayashi, M., Jacobson-Kram, D., Kasper, P., Gollapudi, B., Müller, L. and Uno, Y. (2011) Summary of major conclusions from the 5th IWGT Basel, Switzerland, 17-19 August, 2009. Mutat. Res., 723, 73-76.
4. ®, a reconstructed human skin model: towards new tools for in vitro risk assessment of dermally applied compounds? Mutat. Res., 606, 39-51.
5. van Herwaarden, A. E., van Waterschoot, R. A. B. and Schinkel, A. H. (2009) How important is intestinal cytochrome P450 3A metabolism? Trends Pharmacol. Sci., 30, 223-227.
6. van Waterschoot, R. A. B. and Schinkel, A. H. (2011) A critical analysis of the interplay between cytochrome P450 3A and P-glycoprotein: recent insights from knockout and transgenic mice. Pharmacol. Rev., 63, 390.
7. Hidalgo, I. J., Raub, T. and Borchardt, R. (1989) Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology, 96, 736-749.
8. Meunier, V., Bourrie, M., Berger, Y. and Fabre, G. (1995) The human intestinal epithelial cell line Caco-2; pharmacological and pharmacokinetic applications. Cell Biol. Toxicol., 11, 187-194.
9. Lampen, A., Bader, A., Bestmann, T., Winkler, M., Witte, L. and Borlak, J. (1998) Catalytic activities, protein-and mRNA-expression of cytochrome P450 isoenzymes in intestinal cell lines. Xenobiotica, 28, 429-441.
10. Tamura, H., Taniguchi, K., Hayashi, E., Hiyoshi, Y. and Nagai, F. (2001) Expression profling of sulfotransferases in human cell lines derived from extra-hepatic tissues. Biol. Pharm. Bull., 24, 1258-1262.
11. Hunter, J., Jepson, M., Tsuruo, T., Simmons, N. and Hirst, B. (1993) Functional expression of P-glycoprotein in apical membranes of human intestinal Caco-2 cells. Kinetics of vinblastine secretion and interaction with modulators. J. Biol. Chem., 268, 14991.
12. Nesslany, F. and Marzin, D. (2010) Cytosine arabinoside, vinblastine, diethylstilboestrol and 2-aminoanthracene tested in the in vitro human TK6 cell line micronucleus test (MNvit) at Institut Pasteur de Lille in support of OECD draft test guideline 487. Mutat. Res., 702, 212-218.
13. Fowler, P., Whitwell, J., Jeffrey, L., Young, J., Smith, K. and Kirkland, D. (2010) Cadmium chloride, benzo[a]pyrene and cyclophosphamide tested in the in vitro mammalian cell micronucleus test (MNvit) in the human lymphoblastoid cell line TK6 at Covance laboratories, Harrogate UK in support of OECD draft Test Guideline 487. Mutat. Res., 702, 171-174.
14. Platel, A., Nesslany, F., Gervais, V. and Marzin, D. (2009) Study of oxida-tive DNA damage in TK6 human lymphoblastoid cells by use of the in vitro micronucleus test: determination of No-Observed-Effect Levels. Mutat. Res., 678, 30-37.
15. Bazin, E., Mourot, A., Humpage, A. R. and Fessard, V. (2010) Genotoxicity of a freshwater cyanotoxin, cylindrospermopsin, in two human cell lines: Caco 2 and HepaRG. Environ. Mol. Mutagen., 51, 251-259.
16. Fessard, V. and Le Hegarat, L. (2011) Caco 2 cells and genotoxicity studies of food contaminants. In Schulz, M. A. (ed.), CACO-2 Cells and Their Uses. Novapublishers, pp. 113-128.
17. Fenech, M., Chang, W. P., Kirsch-Volders, M., Holland, N., Bonassi, S. and Zeiger, E. (2003) HUMN project: detailed description of the scoring criteria for the cytokinesis-block micronucleus assay using isolated human lymphocyte cultures. Mutat. Res., 534, 65-75.
18. Kirsch-Volders, M., Sofuni, T., Aardema, M. et al. (2003) Report from the in vitro micronucleus assay working group. Mutat. Res., 540, 153-163.
19. Kirkland, D. (2010) Evaluation of different cytotoxic and cytostatic measures for the in vitro micronucleus test (MNVit): summary of results in the collaborative trial. Mutat. Res., 702, 135-138.
20. Sun, H. and Pang, K. S. (2008) Permeability, transport, and metabolism of solutes in Caco-2 cell monolayers: a theoretical study. Drug Metab. Dispos., 36, 102-123.
21. Sun, H., Chow, E. C. Y., Liu, S., Du, Y. and Pang, K. S. (2008) The Caco-2 cell monolayer: usefulness and limitations. Expert Opin. Drug Metab. Toxicol., 4, 395-411.
22. Buhrke, T., Weißhaar, R. and Lampen, A. (2011) Absorption and metabolism of the food contaminant 3-chloro-1, 2-propanediol (3-MCPD) and its fatty acid esters by human intestinal Caco-2 cells. Arch. Toxicol., 85, 1201-1208.
23. Paine, M. F., Hart, H. L., Ludington, S. S., Haining, R. L., Rettie, A. E. and Zeldin, D. C. (2006) The human intestinal cytochrome P450 "pie". Drug Metab. Dispos., 34, 880-886.
24. Kim, J. H., Stansbury, K. H., Walker, N. J., Trush, M. A., Strickland, P. T. and Sutter, T. R. (1998) Metabolism of benzo[a]pyrene and benzo[a]pyrene-7, 8-diol by human cytochrome P450 1B1. Carcinogenesis, 19, 1847.
25. Ebert, B., Seidel, A. and Lampen, A. (2005) Identifcation of BCRP as transporter of benzo[a]pyrene conjugates metabolically formed in Caco-2 cells and its induction by Ah-receptor agonists. Carcinogenesis, 26, 1754-1763.
26. Niestroy, J., Barbara, A., Herbst, K., Rode, S., van Liempt, M. and Roos, P. H. (2011) Single and concerted effects of benzo[a]pyrene and favo-noids on the Ahr and Nrf2-pathway in the human colon carcinoma cell line Caco-2. Toxicol. In Vitro, 25, 671-683.
27. de Waard, P. W. J., de Kok, T. M. C. M., Maas, L. M., Peijnenburg, A. A. C. M., Hoogenboom, R. L. A. P., Aarts, J. M. and van Schooten, F. J. (2008) Infuence of TCDD and natural Ah receptor agonists on benzo[a]pyrene-DNA adduct formation in the Caco-2 human colon cell line. Mutagenesis, 23, 67-73.
28. Audebert, M., Riu, A., Jacques, C., Hillenweck, A., Jamin, E., Zalko, D. and Cravedi, J. (2010) Use of the [gamma] H2AX assay for assessing the genotoxicity of polycyclic aromatic hydrocarbons in human cell lines. Toxicol. Lett., 199, 182-192.
29. Lazarova, M. and Slameova, D. (2004) Genotoxic effects of a complex mixture adsorbed onto ambient air particles on human cells in vitro; the effects of Vitamins E and C. Mutat. Res., 557, 167-175.
30. Choi, S. H., Fukuda, O., Sakoda, A. and Sakai, Y. (2004) Enhanced cytochrome P450 capacities of Caco-2 and Hep G2 cells in new cocul-ture system under the static and perfused conditions: evidence for possible organ-to-organ interactions against exogenous stimuli. Mat. Sci. Eng. C, 24, 333-339.
31. Buesen, R., Mock, M., Nau, H., Seidel, A., Jacob, J. and Lampen, A. (2003) Human intestinal Caco-2 cells display active transport of benzo[a]pyrene metabolites. Chem Biol. Interact., 142, 201-221.
32. Buesen, R., Mock, M., Seidel, A., Jacob, J. and Lampen, A. (2002) Interaction between metabolism and transport of benzo[a]pyrene and its metabolites in enterocytes. Toxicol. Appl. Pharmacol., 183, 168-178.
33. Fang, C. and Zhang, Q. Y. (2010) The role of small-intestinal P450 enzymes in protection against systemic exposure of orally administered benzo[a]pyrene. J. Pharmacol. Exp. Ther., 334, 156-163.
34. Sinha, R., Kulldorff, M., Gunter, M. J., Strickland, P. and Rothman, N. (2005) Dietary benzo[a]pyrene intake and risk of colorectal adenoma. Cancer Epidemiol. Biomarkers Prev., 14, 2030-2034.
35. Macé, K., Offord, E. A. and Pfeifer, A. M. A. (1997) Drug metabolism and carcinogen activation studies with human genetically engineered cells. In Vitro Meth. Pharm. Res., 433-456.
36. Ueng, Y. F., Shimada, T., Yamazaki, H. and Guengerich, F. P. (1995) Oxidation of afatoxin B1 by bacterial recombinant It is a book chapter human cytochrome P450 enzymes. Chem. Res. Toxicol., 8, 218-225.
37. Schmiedlin-Ren, P., Thummel, K. E., Fisher, J. M., Paine, M. F., Lown, K. S. and Watkins, P. B. (1997) Expression of enzymatically active CYP3A4 by Caco-2 cells grown on extracellular matrix-coated permeable supports in the presence of 1, 25-dihydroxyvitamin D3. Mol. Pharmacol., 51, 741.
38. Sergent, T., Dupont, I., Van Der Heiden, E., Scippo, M. L., Pussemier, L., Larondelle, Y. and Schneider, Y. J. (2009) CYP1A1 and CYP3A4 modulation by dietary favonoids in human intestinal Caco-2 cells. Toxicol. Lett., 191, 216-222.
39. Aiba, T., Susa, M., Fukumori, S. and Hashimoto, Y. (2005) The effects of culture conditions on CYP3A4 and MDR1 mRNA induction by 1, 25-dihydroxyvitamin D3 in human intestinal cell lines, Caco-2 and LS180. Drug Metab. Pharm., 20, 268-274.
40. Wild, C. and Turner, P. (2002) The toxicology of afatoxins as a basis for public health decisions. Mutagenesis, 17, 471.
41. Kamdem, L. K., Meineke, I., GÖdtel-Armbrust, U., BrockmÖller, J. and Wojnowski, L. (2006) Dominant contribution of P450 3A4 to the hepatic carcinogenic activation of afatoxin B1. Chem. Res. Toxicol., 19, 577-586.